We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Highly Sensitive Thyroglobulin Chemiluminescent Microparticle Immunoassay Evaluated

By LabMedica International staff writers
Posted on 20 Jul 2022
Print article
Image: The Alinity I Immunoassay analyzer (Photo courtesy of Abbott)
Image: The Alinity I Immunoassay analyzer (Photo courtesy of Abbott)

Differentiated thyroid cancer (DTC) is the most frequent endocrine malignancy. Standard treatment of DTC is thyroidectomy plus, for high risk cases, radioactive iodine ablation therapy, and pharmacological suppression of TSH.

Thyroglobulin (Tg) measurement is an essential diagnostic element of the follow-up and management of patients with differentiated thyroid cancer (DTC), as the 660 kDa glycoprotein is exclusively produced by benign or well-differentiated malignant thyroid cells. Tg is the matrix for synthesis and storage form of thyroxine (T4) and triiodothyronine (T3) within the thyroid follicles.

Clinical Biochemists at the University Health Network (UHN, Toronto, ON, Canada) participated in a three-center study, Tg values of 447 routine patient samples, characterized for the presence of anti-Tg. Mostly fresh samples from routine Tg requests were used. In addition, frozen samples, and precision and limit of quantitation patient pools and controls were utilized.

Samples were measured on ARCHITECT i2000SR (Abbott, Abbott Park, IL, USA) at three sites and Abbott’s Alinity i analyzer at one site using respective Tg and anti-Tg reagents, calibrators, and controls. For method comparison, samples were measured on a cobas 411 (Roche Diagnostics, Rotkreuz, Switzerland) at all three sites and on UniCel DxI 800 (Beckman Coulter, Brea, CA, USA) at one site using respective reagents, calibrators, and controls. Anti-Tg status was determined using Alinity i anti-Tg assay or ARCHITECT anti-Tg.

Serum Tg measured using with ARCHITECT was compared with the Roche Elecsys Tg II results. In total, 447 patient samples were analyzed for ARCHITECT and Roche with 56 samples positive for anti-Tg (cutoff 4.1 IU/mL). ARCHITECT Tg concentrations were ranging from 0.09 to 486 ng/mL for anti-Tg-negative and 0.09 to 341 ng/mL for anti-Tg-positive samples. Roche Tg values were closely correlated, with a correlation coefficient greater than 0.98 and a slope within 0.9–1.1 for anti-Tg-negative and anti-Tg-positive samples. Limit of quantitation (LoQ) was verified to be less than or equal to 0.1 ng/mL confirming that the Tg assay on ARCHITECT and Alinity was highly sensitive.

The authors concluded that the Abbott Thyroglobulin assay, which is standardized to the human thyroglobulin reference material (CRM-457), demonstrated a high correlation to the Roche and Beckman Tg assays, though good agreement of absolute values was only observed between Abbott and Roche. Strength of correlation and slope were not affected by the presence of anti-Tg indicating that all assays included in the study have a similar susceptibility to anti-Tg. The study was published on July 15, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
University Health Network 
Abbott
Roche Diagnostics 
Beckman Coulter 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.